Eli Lilly (LLY) raises 2026 guidance after Q1 beat: what income investors should know
Eli Lilly (NYSE: LLY) reported Q1 2026 earnings that beat analyst estimates and raised its full-year guidance, sending the stock up 3.07% on April 30. Revenue is now projected between $82 billion and $85 billion. […]
Eli Lilly (LLY) raises 2026 guidance after Q1 beat: what income investors should know Read More »
